Prevalence and Pattern of Geographic Atrophy in Asia: The Asian Eye Epidemiology Consortium.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
10 2020
Historique:
received: 04 12 2019
revised: 23 03 2020
accepted: 13 04 2020
pubmed: 29 4 2020
medline: 16 12 2020
entrez: 29 4 2020
Statut: ppublish

Résumé

Although there have been many population-based studies of age-related macular degeneration (AMD), only limited information is available in Asia on the epidemiology of geographic atrophy (GA). We aimed to determine the prevalence and patterns of GA through an analysis of multiple studies conducted within the Asian Eye Epidemiology Consortium (AEEC). Cross-sectional meta-analyses. A total of 97 213 individuals aged 40 years and older. Data from 22 population-based studies from countries belonging to the AEEC were included. In all studies, AMD was defined on the basis of standardized grading systems. Geographic atrophy was defined as an area of pallor in the fundus with visibility of the underlying choroidal blood vessels and sharply defined borders. Random-effects meta-analysis was performed to estimate overall and age-, gender-, and region-specific pooled prevalence of GA. Prevalence of GA per 1000 persons. The mean age was 60.8 ± 10.0 years, and 42 673 (43.9%) were male. Overall, a total of 223 individuals (0.2%) had GA. The pooled overall prevalence of GA was 1.57 per 1000 persons (95% confidence interval [CI], 1.04-2.10), which was 3 times less than that of neovascular AMD of 5.20 per 1000 persons (95% CI, 3.97-6.43). Compared with those aged 50 to 59 years, the prevalence of GA increased from 0.34 per 1000 persons (95% CI, 0.07-0.62) to 2.90 per 1000 persons (95% CI, 1.55-4.25) in those aged ≥70 years. The GA prevalence per 1000 persons was similar between urban (2.22; 95% CI, 1.22-3.23) and rural residents (1.33; 95% CI, 0.70-1.96). Geographic atrophy was more prevalent in South Asia (based on studies from India and Nepal, 3.82 per 1000 persons; 95% CI, 1.72-5.93) compared with East Asia (based on studies from China, Korea, Hong Kong, Taiwan, and Japan, and the Singapore Chinese Eye Study, 0.76 per 1000 persons; 95% CI, 0.31-1.22, P = 0.005). Geographic atrophy is uncommon in Asian populations compared with those of European ancestry. Even within Asia, geographic differences in GA prevalence were seen. The findings of this meta-analysis suggest that better dissection of risk factors in the Asian population for GA may provide insights into the biological pathways that drive these late-stage manifestations, thus suggesting better targets for prevention.

Identifiants

pubmed: 32344073
pii: S0161-6420(20)30395-X
doi: 10.1016/j.ophtha.2020.04.019
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1371-1381

Investigateurs

Achareeya Saenmee (A)
Kai Cao (K)
Ronnie George (R)
Gyulli M Kazakbaeva (GM)
Timur A Khalimov (TA)
Rohit C Khanna (RC)
Hyun Woong Kim (HW)
Vaitheeswaran Kulothungan (V)
Prabhat Nangia (P)
Feifei Mao (F)
Fumihiko Matsuda (F)
Qianli Meng (Q)
Hiroyuki Namba (H)
Nattapol Pokawattana (N)
Jaeryung Oh (J)
Sang Jun Park (SJ)
Ravilla Ravindran (R)
Tarun Sharma (T)
Jae Pil Shin (JP)
Janani Surya (J)
Ayako Takahashi (A)
Toru Takebayashi (T)
Akitaka Tsujikawa (A)
Praveen Vashist (P)
Wen Bin Wei (WB)
Xiaohui Yang (X)
Seung-Young Yu (SY)
Rinat M Zainullin (RM)
Pei Quan Zhao (PQ)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Tyler Hyungtaek Rim (TH)

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Ophthalmology & Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore.

Ryo Kawasaki (R)

Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan; Ganka Ekigaku Network, Osaka, Japan.

Yih-Chung Tham (YC)

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Ophthalmology & Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore.

Se Woong Kang (SW)

Department of Ophthalmology of Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Paisan Ruamviboonsuk (P)

Department of Ophthalmology, Rajavithi Hospital, Bangkok, Thailand.

Mukharram M Bikbov (MM)

Ufa Eye Research Institute, Ufa, Russia.

Masahiro Miyake (M)

Ganka Ekigaku Network, Osaka, Japan; Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Jie Hao (J)

Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Astrid Fletcher (A)

London School of Hygiene & Tropical Medicine, London, United Kingdom.

Mariko Sasaki (M)

Ganka Ekigaku Network, Osaka, Japan; Department of Ophthalmology, Keio University school of medicine, Tokyo, Japan.

Vinay Nangia (V)

Suraj Eye Institute, Nagpur, India.

Charumathi Sabanayagam (C)

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Ophthalmology & Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore.

Marco Yu (M)

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.

Kohta Fujiwara (K)

Ganka Ekigaku Network, Osaka, Japan; Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Raba Thapa (R)

Tilganga Institute of Ophthalmology, Kathmandu, Nepal.

Ian Y Wong (IY)

University of Hong Kong and Hong Kong Sanatorium and Hospital, Hong Kong.

Takamasa Kayama (T)

Yamagata University Faculty of Medicine, Yamagata, Japan.

Shih-Jen Chen (SJ)

Department of Ophthalmology, Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University, Taipei, Taiwan.

Tung-Mei Kuang (TM)

Department of Ophthalmology, Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University, Taipei, Taiwan.

Hidetoshi Yamashita (H)

Yamagata University Faculty of Medicine, Yamagata, Japan.

Periasamy Sundaresan (P)

Department of Molecular Genetics, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India.

Jonathan C Chan (JC)

Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.

G H M B van Rens (GHMB)

Department of Ophthalmology, Amsterdam University Medical Center, Vrije University Amsterdam, Amsterdam, The Netherlands.

Koh-Hei Sonoda (KH)

Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Ya Xing Wang (YX)

Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Songhomitra Panda-Jonas (S)

Augenpraxis Jonas, Heidelberg, Germany.

Sei Harada (S)

Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.

Ramasamy Kim (R)

Department of Ophthalmology, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

Suganeswari Ganesan (S)

Medical Research Foundation, Sankara Nethralaya, Chennai, India.

Rajiv Raman (R)

Medical Research Foundation, Sankara Nethralaya, Chennai, India.

Kenji Yamashiro (K)

Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Ophthalmology, Otsu Red Cross Hospital, Otsu, Japan.

Timur R Gilmanshin (TR)

Ufa Eye Research Institute, Ufa, Russia.

Watanee Jenchitr (W)

Rangsit Eye Center and Faculty of Optometry, Rangsit University, Bangkok, Thailand.

Kyu Hyung Park (KH)

Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.

Chui Ming Gemmy Cheung (CM)

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Ophthalmology & Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore.

Tien Yin Wong (TY)

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Ophthalmology & Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore.

Ningli Wang (N)

Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Jost B Jonas (JB)

Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Usha Chakravarthy (U)

Queen's University of Belfast, Belfast, Northern Ireland.

Ching-Yu Cheng (CY)

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Ophthalmology & Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore. Electronic address: chingyu.cheng@duke-nus.edu.sg.

Yasuo Yanagi (Y)

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Ganka Ekigaku Network, Osaka, Japan; Department of Ophthalmology, Asahikawa Medical University, Hokkaido, Japan. Electronic address: yasuo.yanagi.asahikawa@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH